title: QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus.
authors.forename: Emanuel
authors.initials: E
authors.lastname: Raschi
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Poluzzi
authors.forename: Ariola
authors.initials: A
authors.lastname: Koci
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Boriani
authors.forename: Fabrizio
authors.initials: F
authors.lastname: De Ponti
mesh_terms: D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D064420:Drug-Related Side Effects and Adverse Reactions; D004562:Electrocardiography / Q000379:methods; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D014481:United States; D014486:United States Food and Drug Administration